Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Clinical Trial
|
| gptkbp:aimsTo |
Safety_and_Efficacy
|
| gptkbp:focusesOn |
Laser_Technology
|
| gptkbp:hasCapacity |
Diverse Population
Different Age Groups Varied Ethnicities |
| gptkbp:hasCharacter |
Phase II
Phase III Phase I |
| gptkbp:hasCollaboratedWith |
Research Institutions
Universities Healthcare_Providers |
| gptkbp:hasCollection |
Surveys
Clinical Assessments Follow-up_Visits |
| gptkbp:hasExhibition |
Pregnant Women
Severe Eye Diseases |
| gptkbp:hasFacilities |
Reduction in Complications
|
| gptkbp:hasFacility |
gptkb:WaveLight_Technologies
Multiple Locations |
| gptkbp:hasParticipatedIn |
Patients with Vision Impairment
|
| gptkbp:hasPerformedAt |
Medical Conferences
|
| gptkbp:hasPriorityDate |
2022-01-01
2023-12-31 |
| gptkbp:hasSpecialty |
Patient Satisfaction
Visual Acuity Improvement in Vision |
| gptkbp:hasStudentOrganizations |
Age 18 and Older
|
| https://www.w3.org/2000/01/rdf-schema#label |
WaveLight Clinical Trials
|
| gptkbp:isAttendedBy |
gptkb:FDA
|
| gptkbp:isCounteredBy |
gptkb:Canada
gptkb:Germany gptkb:United_Kingdom gptkb:United_States |
| gptkbp:isEvaluatedBy |
Statistical Analysis
Quality of Life Long-term Effects Short-term Effects |
| gptkbp:isFundedBy |
Private Investors
|
| gptkbp:isMonitoredBy |
Independent_Review_Board
|
| gptkbp:isPartOf |
Clinical_Research_Network
WaveLight_Research_Program |
| gptkbp:isPortrayedBy |
Annual Reports
Clinical_Researchers |
| gptkbp:isPublishedIn |
Medical Journals
|
| gptkbp:isRegulatedBy |
ClinicalTrials.gov
|
| gptkbp:isRelatedTo |
Vision Correction
|
| gptkbp:isReviewedBy |
Peer Reviewers
|
| gptkbp:isSupportedBy |
Grants
Medical_Associations |
| gptkbp:isUtilizedFor |
Best Practices
Clinical Guidelines Patient_Education |
| gptkbp:usesTechnology |
gptkb:Laser-Assisted_Surgery
gptkb:WaveLight_Laser_System Refractive Surgery Ophthalmic Devices |